Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020		Jun. 30, 2019	[1]
Operating activities:
Net (loss)/income	$ (2,061)		$ 1,346	[2],[3]
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Amortization of deferred financing costs	29		19
Depreciation and amortization	646		614	[3]
Goodwill and Intangible Asset Impairment	2,165		0	[3]
Deferred income taxes	(1)		(2)
Retirement Expenditures	0		1
Loss/(gain) on disposal of assets	1		(2)
Loss/(income) from equity method investments(2)	1,095	[4],[5]	(160)	[3]
Distributions from unconsolidated affiliates	226		245
Changes in:
Current receivables	31		75
Inventories	(7)		0
Fair value of derivatives	(9)		7
Current accounts payable and accrued liabilities	(102)		(117)
Current assets/current liabilities - related parties	27		(124)
Increase (Decrease) in Other Operating Assets and Liabilities, Net	(1)		1
Deferred revenue	49		46
All other, net	26		7
Net cash provided by operating activities	2,114		1,954
Investing activities:
Additions to property, plant and equipment	(708)		(1,136)
Proceeds from Contributions from Affiliates	0		6
Disposal of assets	43		8
Investments in unconsolidated affiliates	(222)		(323)
Distributions from unconsolidated affiliates - return of capital	110		2
Payments for (Proceeds from) Other Investing Activities	0		(4)
Net cash used in investing activities	(777)		(1,439)
Financing activities:
Long-term debt - borrowings	2,500		3,139
Long-term debt - repayments	(1,682)		(2,272)
Related party debt - borrowings	2,708		3,833
Related party debt - repayments	(3,302)		(3,789)
Distributions to noncontrolling interests	(17)		(12)
Distributions to unitholders and general partner	(1,445)		(1,038)
Proceeds from Contributions from Parent	20		28
Contributions from noncontrolling interests	0		94
All other, net	(5)		(9)
Net cash used in financing activities	(1,285)		(568)
Net increase/(decrease) in cash, cash equivalents and restricted cash	52		(53)
Cash, cash equivalents and restricted cash at beginning of period	15		85
Cash, cash equivalents and restricted cash at end of period	67		32
Equity Method Investment, Other than Temporary Impairment	1,264
Series A Preferred Stock [Member] | Preferred Partner [Member]
Financing activities:
Distributions to preferred unitholders	(41)		(40)
Series B Preferred Stock [Member] | Preferred Partner [Member]
Financing activities:
Distributions to preferred unitholders	(21)		0
Payments of Distributions on Preferred Units from Predecessor	$ 0		$ 502

[1] Financial information for the six months ended June 30, 2019 has been retrospectively adjusted for the acquisition of ANDX. See Notes 1 and 3.

[2] Financial information for the three and six months ended June 30, 2019 has been retrospectively adjusted for the acquisition of ANDX. See Notes 1 and 3.

[3] Financial information for the three and six months ended June 30, 2019 has been retrospectively adjusted for the acquisition of ANDX. See Notes 1 and 3.

[4] The 2020 period includes $1,264 million of impairment expense. See Note 4.

[5] The six months ended June 30, 2020 includes $1,264 million of impairment expense. See Note 4.